Overview

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Korean Study Participants With Moderate to Severe Plaque Psoriasis

Status:
Recruiting
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy and safety of bimekizumab compared with placebo.
Phase:
Phase 3
Details
Lead Sponsor:
UCB Biopharma SRL